US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beta Bionics, Inc.

19.08

-0.4700-2.40%

Pre-market: 18.77-0.3100-1.62%08:00 EDT

Volume:583.62K

Turnover:11.23M

Market Cap:827.24M

PE:-3.37

High:20.19

Open:19.96

Low:18.35

Close:19.55

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Beta Bionics, Inc. (BBNX)

Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Alnylam Pharma (ALNY) and Beta Bionics, Inc. (BBNX)

Beta Bionics Reports Q4 Loss as Sales Rise; Sets 2025 Revenue Guidance

MT Newswires Live

Beta Bionics Q4 2024 GAAP EPS $(2.72) Beats $(2.91) Estimate, Sales $20.400M Beat $20.187M Estimate

Beta Bionics Inc Outlook 2025 Total Revenue of Approximately $80 Mln to $85 Mln

THOMSON REUTERS

Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025

Calendar of U.S. Earnings Expected in the Week Ahead

Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

BUZZ-U.S. STOCKS ON THE MOVE- Eli Lilly, Krispy Kreme, PayPal

BUZZ-BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating

Beta Bionics initiated with a Buy at BofA

BUZZ-Wall Street bullish on insulin device maker Beta Bionics after IPO

Beta Bionics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $28

THOMSON REUTERS

Beta Bionics Initiated at Outperform by Leerink Partners

Stifel Initiates Beta Bionics at Buy With $25 Price Target

MT Newswires Live

Piper Sandler Initiates Beta Bionics at Overweight With $26 Price Target

MT Newswires Live

Leerink Partners Initiates Beta Bionics at Outperform With $28 Price Target

MT Newswires Live

Beta Bionics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $25

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC) and Beta Bionics, Inc. (BBNX)

Beta Bionics initiated with an Overweight at Piper Sandler

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BBNX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBNX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","market":"US","secType":"STK","nameCN":"Beta Bionics, Inc.","latestPrice":19.08,"timestamp":1749240000000,"preClose":19.55,"halted":0,"volume":583624,"hourTrading":{"tag":"盘前","latestPrice":18.77,"preClose":19.08,"latestTime":"08:00 EDT","volume":219,"amount":4094.459697,"timestamp":1749470447577},"delay":0,"floatShares":26447773,"shares":43356281,"eps":-5.659705,"marketStatus":"Pre-Mkt","change":-0.47,"latestTime":"06-09 08:54:12 EDT","open":19.96,"high":20.19,"low":18.35,"amount":11232005.543848,"amplitude":0.094118,"askPrice":22,"askSize":50,"bidPrice":18,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-5.659705,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1749475800000},"marketStatusCode":1,"adr":0,"listingDate":1738213200000,"exchange":"NASDAQ","adjPreClose":19.08,"preHourTrading":{"tag":"盘前","latestPrice":18.77,"preClose":19.08,"latestTime":"08:00 EDT","volume":219,"amount":4094.459697,"timestamp":1749470447577},"postHourTrading":{"tag":"盘后","latestPrice":19.08,"preClose":19.08,"latestTime":"19:48 EDT","volume":1333,"amount":25425.38,"timestamp":1749253710766},"volumeRatio":0.6621030778657779},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBNX\",,,,,undefined,":{"symbol":"BBNX","floatShares":26447773,"roa":"-21.78%","roe":"-81.35%","lyrEps":-8.602584,"volumeRatio":0.6621030778657779,"shares":43356281,"dividePrice":0,"high":20.19,"amplitude":0.094118,"preClose":19.55,"low":18.35,"week52Low":8.89,"pbRate":"2.64","psRate":"11.85","week52High":24.5,"institutionHeld":0,"latestPrice":19.08,"committee":-0.886792,"eps":-5.659705,"divideRate":0,"volume":583624,"delay":0,"ttmEps":-5.659705,"open":19.96,"prevYearClose":17,"prevWeekClose":19.08,"prevMonthClose":17.24,"prevQuarterClose":12.24,"fiveDayClose":17.24,"twentyDayClose":14.91,"sixtyDayClose":14.5},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBNX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522805384","title":"Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI) and Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522805384","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522805384?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:00","pubTimestamp":1742994009,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on TriSalus Life Sciences (TLSI – Research Report) and ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-trisalus-life-sciences-tlsi-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLSI","BBNX","BK4082","HCSG","BK4137","BK4139"],"gpt_icon":0},{"id":"2522061822","title":"Analysts Offer Insights on Healthcare Companies: Dexcom (DXCM), Alnylam Pharma (ALNY) and Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522061822","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522061822?lang=en_us&edition=fundamental","pubTime":"2025-03-26 18:40","pubTimestamp":1742985625,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Dexcom (DXCM – Research Report), Alnylam Pharma (ALN...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dexcom-dxcm-alnylam-pharma-alny-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-dexcom-dxcm-alnylam-pharma-alny-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","LU2433249047.HKD","LU2125909593.SGD","IE00BMPRXN33.USD","LU0354030438.USD","LU2211815571.USD","DXCM","ALNY","BBNX","BK4137","BK4139","LU0354030511.USD","HCSG","LU1923622614.USD","BK4551","LU0266013472.USD","BK4082","BK4588","ALN","LU1323610961.USD","BK4504","BK4548","BK4585","LU2125909247.SGD","IE00BMPRXR70.SGD"],"gpt_icon":0},{"id":"2522915833","title":"Beta Bionics Reports Q4 Loss as Sales Rise; Sets 2025 Revenue Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2522915833","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522915833?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:50","pubTimestamp":1742935835,"startTime":"0","endTime":"0","summary":"Beta Bionics  reported a Q4 net loss late Tuesday of $2.72 per diluted share.The company did not provide a year-ago per-share figure.Analysts polled by Factset expected a loss of $0.90.Net sales for the quarter ended Dec. 31 were $20.4 million, up from $8.4 million a year earlier.Analysts surveyed by Factset expected $20.2 million.The company set full-year 2025 revenue guidance between $80 million and $85 million.Analysts polled by Factset expect $85.1 million.Beta Bionics completed its initial public offering on Jan. 30, listing on the Nasdaq Global Market.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2522887701","title":"Beta Bionics Q4 2024 GAAP EPS $(2.72) Beats $(2.91) Estimate, Sales $20.400M Beat $20.187M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522887701","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522887701?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:09","pubTimestamp":1742933340,"startTime":"0","endTime":"0","summary":"Beta Bionics Q4 2024 GAAP EPS $(2.72) Beats $(2.91) Estimate, Sales $20.400M Beat $20.187M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44481372/beta-bionics-q4-2024-gaap-eps-2-72-beats-2-91-estimate-sales-20-400m-beat-20-187m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2522875098","title":"Beta Bionics Inc Outlook 2025 Total Revenue of Approximately $80 Mln to $85 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2522875098","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522875098?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:02","pubTimestamp":1742932921,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250325:nTUA672JQT:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2522757838","title":"Beta Bionics Announces Fourth Quarter and Full Year 2024 Financial Results and Introduces Annual Guidance for Full Year 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2522757838","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522757838?lang=en_us&edition=fundamental","pubTime":"2025-03-26 04:02","pubTimestamp":1742932920,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., March 25, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter and year ended December 31, 2024 and introduced its annual guidance for the year ending December 31, 2025.Fourth Quarter 2024 Financial Highlights & Key Metrics. Net sales of $20.4 million, up 145% compared to $8.4 million in the fourth quarter of 2023.Durable Medical Equipment  channel net sales of $18.1 million, up 127% compared to $7.9 million in the fourth quarter of 2023.Pharmacy Benefit Plan  channel net sales of $2.4 million, up 491% compared to $0.4 million in the fourth quarter of 2023.Installed customer base  of 15,298 users, up 564% compared to 2,304 in the fourth quarter of 2023.4,084 new patient starts, up 125% compared to 1,818 new patient starts in the fourth quarter of 2023.70% of new patient starts came from multiple daily injections .Low-teens percentage of new patient starts reim","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beta-bionics-announces-fourth-quarter-200200338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BBNX","PBP","BK4082"],"gpt_icon":0},{"id":"2520439968","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2520439968","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520439968?lang=en_us&edition=fundamental","pubTime":"2025-03-20 18:00","pubTimestamp":1742464800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Amprius Tech Inc                                4Q      (.11)  4:05 PM. ·Lands' End Inc.                                   4Q       .57   6:45 AM. ·Lennar Corp Class A                              1Q      1.70       AMC","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BRNS","PL","BRAG","BLRX","COYA","SOWG","KLC","CELC","MNSO","WOR","FBRX","MREO","MGNX","FLUX","ACRV","LPTX","OUST","NKE","SLS","TELA","ASO","GDEV","JKS","DRI","ALUR","PAYX","RLMD","THRD","SKYE","CURV","DERM","IFRX","CMC","LVTX","TH","MBRX","JEF","LEN","RUM","CBUS","BCAB","MLKN","SBS","TITN","SPRY","BBNX","CDLR","NKTX"],"gpt_icon":1},{"id":"2514053418","title":"Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2514053418","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514053418?lang=en_us&edition=fundamental","pubTime":"2025-02-27 20:00","pubTimestamp":1740657600,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Feb. 27, 2025  -- Beta Bionics, Inc. , a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its fourth quarter and full year 2024 financial results after the financial markets close on Tuesday, March 25, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time , to review the company’s fourth quarter and full year 2024 performance.Media and Public Relations: Karen HynesVice President of Marketingmedia@betabionics.com","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/beta-bionics-announce-fourth-quarter-120000112.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2514097110","title":"BUZZ-U.S. STOCKS ON THE MOVE-  Eli Lilly, Krispy Kreme, PayPal","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097110","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514097110?lang=en_us&edition=fundamental","pubTime":"2025-02-25 22:30","pubTimestamp":1740493805,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE- Eli Lilly, Krispy Kreme, PayPalEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: h","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL6N3PG0G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRE","BBNX","CHGG","AS","ZM","NVD3.UK","CAKE","NVDS.UK","3NVD.UK","DNUT","CLF","DOMH","BKSY","NVD2.UK","ONVO","AU","LLY","HD","NIO.SI","CSCO","CIVI","NTRA","EVER","PLNT","EVS.SI","NVIW.SI","02020","YY","IART","KDP","HRMY","NEM","PYPL","PTLO","MTSR","SNVD.UK"],"gpt_icon":1},{"id":"2514709525","title":"BUZZ-BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2514709525","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514709525?lang=en_us&edition=fundamental","pubTime":"2025-02-25 20:42","pubTimestamp":1740487363,"startTime":"0","endTime":"0","summary":"BUZZ-BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating** BofA Global Research starts coverage on insulin device maker Beta Bionics BBNX.O with \"buy\" rating and $25 PT, citing its \"differentiated closed-loop algorithm\" that simplifies insulin-dosing for diabetic patients** PT represents a 21.4% upside to stock's last close** Brokerage believes BBNX will help expand the current $2 billion U.S. insulin pump market, which has only seen 7% penetration growth in seven years** Co's iLet insulin pump's simplicity can help those taking daily insulin injections switch to a simpler way - BofA** Brokerage expects BBNX's revenue to grow by $15 mln in 2025 and $26 mln in 2026** Stock has fallen 12.8% since its Nasdaq debut on 30 Jan  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250225:nL3N3PG140:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX","BAC"],"gpt_icon":0},{"id":"2514693772","title":"Beta Bionics initiated with a Buy at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2514693772","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514693772?lang=en_us&edition=fundamental","pubTime":"2025-02-25 02:21","pubTimestamp":1740421261,"startTime":"0","endTime":"0","summary":"BofA initiated coverage of Beta Bionics (BBNX) with a Buy rating and $25 price target Beta’s iLet insulin pump simplifies insulin-dosing for insuli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-a-buy-at-bofa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2513787567","title":"BUZZ-Wall Street bullish on insulin device maker Beta Bionics after IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2513787567","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513787567?lang=en_us&edition=fundamental","pubTime":"2025-02-24 23:34","pubTimestamp":1740411293,"startTime":"0","endTime":"0","summary":"BUZZ-Wall Street bullish on insulin device maker Beta Bionics after IPO** Wall Street brokerages start coverage of insulin device maker, Beta Bionics BBNX.O, on a bullish note as IPO research quiet pe","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nL3N3PF12B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130103400.USD","LU1074936037.SGD","BK4211","LU0980610538.SGD","LU1718418525.SGD","LU0417517546.SGD","BK4553","LU0640476718.USD","BK4207","LU1201861249.SGD","BK4581","LU0787776722.HKD","LU1880398471.USD","LU0053666078.USD","LU1366192091.USD","LU0149725797.USD","LU1496350171.SGD","BBNX","LU1162221912.USD","LU1894683348.USD","IE00BLSP4452.SGD","BK4589","LU2129689605.HKD","IE0002270589.USD","BK4588","LU0170899867.USD","LU0130518102.USD","LU0683600562.USD","LU1267930227.SGD","BAC","LU2133065610.SGD","IE00BFXG1179.USD","IE00BLSP4239.USD","LU0477156797.USD","LU0971096721.USD","LU0320765646.SGD","LU0321505868.SGD","BK4585","LU1894683264.USD","LU0320765489.SGD","BK4559","BK4504","LU0306807586.USD","IE00B19Z3581.USD","IE00BZ1G4Q59.USD","LU0321505439.SGD","LU0648000940.SGD","SIVBQ","LU0234572021.USD","LU0306806265.USD"],"gpt_icon":1},{"id":"2513723314","title":"Beta Bionics Inc : Leerink Partners Initiates Coverage With Outperform Rating; Target Price $28","url":"https://stock-news.laohu8.com/highlight/detail?id=2513723314","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513723314?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:28","pubTimestamp":1740400085,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF1FU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BBNX"],"gpt_icon":0},{"id":"2513672371","title":"Beta Bionics Initiated at Outperform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2513672371","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513672371?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:23","pubTimestamp":1740399780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BBNX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 24, 2025 07:23 ET (12:23 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBNX"],"gpt_icon":0},{"id":"2513284237","title":"Stifel Initiates Beta Bionics at Buy With $25 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2513284237","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513284237?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:14","pubTimestamp":1740399295,"startTime":"0","endTime":"0","summary":"Stifel Initiates Beta Bionics at Buy With $25 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SF","BBNX"],"gpt_icon":0},{"id":"2513426728","title":"Piper Sandler Initiates Beta Bionics at Overweight With $26 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2513426728","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513426728?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:14","pubTimestamp":1740399286,"startTime":"0","endTime":"0","summary":"Piper Sandler Initiates Beta Bionics at Overweight With $26 Price Target","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2513472892","title":"Leerink Partners Initiates Beta Bionics at Outperform With $28 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2513472892","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513472892?lang=en_us&edition=fundamental","pubTime":"2025-02-24 20:10","pubTimestamp":1740399023,"startTime":"0","endTime":"0","summary":"Leerink Partners Initiates Beta Bionics at Outperform With $28 Price Target","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BBNX"],"gpt_icon":0},{"id":"2513074905","title":"Beta Bionics Inc : Stifel Initiates Coverage With Buy Rating; Target Price $25","url":"https://stock-news.laohu8.com/highlight/detail?id=2513074905","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513074905?lang=en_us&edition=fundamental","pubTime":"2025-02-24 19:00","pubTimestamp":1740394858,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250224:nFWN3PF0OT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBNX","BK4082"],"gpt_icon":0},{"id":"2513741347","title":"Analysts Offer Insights on Healthcare Companies: GE Healthcare Technologies Inc (GEHC) and Beta Bionics, Inc. (BBNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2513741347","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513741347?lang=en_us&edition=fundamental","pubTime":"2025-02-24 18:50","pubTimestamp":1740394210,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on GE Healthcare Technologies Inc (GEHC – Research Repo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-ge-healthcare-technologies-inc-gehc-and-beta-bionics-inc-bbnx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1366333091.USD","LU0124676726.USD","BK4588","LU1261432733.SGD","BK4566","BBNX","LU0943347566.SGD","BK4543","GE","LU0820562030.AUD","GEHC","BK4501","LU0149725797.USD","LU1551013425.SGD","LU2756315664.SGD","LU2756315318.SGD","LU0868494617.USD","BK4187","BK4082","LU1093756325.SGD","LU1280957306.USD","LU0640476718.USD","LU1064131342.USD","BK4585","LU0354030511.USD","LU1093756168.USD","LU1988902786.USD","LU0157215616.USD","BK4206","LU0354030438.USD","LU0689626769.HKD","LU0689472784.USD","LU0820561818.USD","LU0820561909.HKD","LU2264538146.SGD","LU1551013342.USD"],"gpt_icon":0},{"id":"2513749333","title":"Beta Bionics initiated with an Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2513749333","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2513749333?lang=en_us&edition=fundamental","pubTime":"2025-02-24 18:17","pubTimestamp":1740392264,"startTime":"0","endTime":"0","summary":"Piper Sandler analyst Matt O’Brien initiated coverage of Beta Bionics (BBNX) with an Overweight rating and $26 price target The company has a “uniq...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-an-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beta-bionics-initiated-with-an-overweight-at-piper-sandler?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBNX"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":51,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBNX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-06","symbol":"BBNX","fiscalQuarterEnding":"2025/03","expectedEps":-0.51,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.52},{"market":"US","date":"2025-03-25","symbol":"BBNX","fiscalQuarterEnding":"2024/12","expectedEps":-0.42,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742875200000,"reportTimeType":"post","actualEps":-1.82}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBNX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBNX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":8,"updateTime":1748577600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/BBNX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"BBNX","date":"2025-06-06","current":-11.944468,"percent":0.348315,"low":-18.401318,"twenty":-15.890764,"median":-10.161718,"eighty":-8.656151,"high":-3.90273,"avg":-11.499031,"sd":3.483161,"marketCap":847615293},"quantilePoints":[{"date":"2025-01-31","current":-18.262207,"twenty":-16.058067,"median":-12.751858,"eighty":-7.442381,"marketCap":1013479428},{"date":"2025-02-07","current":-18.125788,"twenty":-18.207639,"median":-17.701026,"eighty":-14.679009,"marketCap":1005908733},{"date":"2025-02-14","current":-16.797439,"twenty":-18.139689,"median":-17.569735,"eighty":-16.871579,"marketCap":932190666},{"date":"2025-02-21","current":-16.117818,"twenty":-18.053192,"median":-17.39983,"eighty":-16.806707,"marketCap":894474446},{"date":"2025-02-28","current":-15.376414,"twenty":-17.738096,"median":-16.901699,"eighty":-15.527784,"marketCap":853329479},{"date":"2025-03-07","current":-13.754592,"twenty":-17.625341,"median":-16.797439,"eighty":-14.919215,"marketCap":763324863},{"date":"2025-03-14","current":-10.843036,"twenty":-17.540388,"median":-16.156433,"eighty":-12.952405,"marketCap":601745147},{"date":"2025-03-21","current":-12.117325,"twenty":-17.418365,"median":-15.88613,"eighty":-12.19996,"marketCap":672463060},{"date":"2025-03-28","current":-10.030495,"twenty":-17.316422,"median":-15.090664,"eighty":-11.612243,"marketCap":549229802},{"date":"2025-04-04","current":-8.526317,"twenty":-16.978156,"median":-13.955389,"eighty":-11.224551,"marketCap":466867006},{"date":"2025-04-11","current":-8.462983,"twenty":-16.936452,"median":-12.789848,"eighty":-9.75816,"marketCap":463399099},{"date":"2025-04-17","current":-8.660901,"twenty":-16.843777,"median":-12.343221,"eighty":-9.270489,"marketCap":474236309},{"date":"2025-04-25","current":-8.755902,"twenty":-16.843777,"median":-12.117325,"eighty":-8.660901,"marketCap":479438170},{"date":"2025-05-02","current":-8.819236,"twenty":-16.797439,"median":-11.630778,"eighty":-8.660901,"marketCap":482906077},{"date":"2025-05-09","current":-9.109566,"twenty":-16.202771,"median":-11.468596,"eighty":-8.660901,"marketCap":646442149},{"date":"2025-05-16","current":-8.41306,"twenty":-16.195048,"median":-11.020664,"eighty":-8.526317,"marketCap":597015989},{"date":"2025-05-23","current":-9.476148,"twenty":-16.117818,"median":-10.030495,"eighty":-8.550067,"marketCap":672455918},{"date":"2025-05-30","current":-9.384503,"twenty":-15.951002,"median":-9.677769,"eighty":-8.619734,"marketCap":665952476},{"date":"2025-06-06","current":-11.944468,"twenty":-15.890764,"median":-10.161718,"eighty":-8.656151,"marketCap":847615293}],"updateTime":1749473652663}}}